Tea catechins as a potential alternative anti-infectious agent

References

• McKay DL, Blumberg JB. The role of tea in human health: an update. J. Am. Coll. Nutr.21(1), 1–13 (2002).
   PubMed Web of Science ®Google Scholar
• Feng Q, Kumagai T, Torii Y, Nakamura Y, Osawa T, Uchida K. Anticarcinogenic antioxidants as inhibitors against intracellular oxidative stress. Free Radic. Res.35(6), 779–788 (2001).
   PubMed Web of Science ®Google Scholar
• Amantana A, Santana-Rios G, Butler JA, Xu M, Whanger PD, Dashwood RH. Antimutagenic activity of selenium-enriched green tea toward the heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoline. Biol. Trace Elem. Res.86(2), 177–191 (2002).
   PubMed Web of Science ®Google Scholar
• Embola CW, Sohn OS, Fiala ES, Weisburger JH. Induction of UDP-glucuronosyltransferase 1 (UDP-GT1) gene complex by green tea in male F344 rats. Food Chem. Toxicol.40(6), 841–844 (2002).
   PubMed Web of Science ®Google Scholar
• Kondo T, Ohta T, Igura K, Hara Y, Kaji K. Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding. Cancer Lett.180(2), 139–144 (2002).
   PubMed Web of Science ®Google Scholar
• Pan T, Jankovic J, Le W. Potential therapeutic properties of green tea polyphenols in Parkinson’s disease. Drugs Aging20(10), 711–721 (2003).
   PubMed Web of Science ®Google Scholar
• Wu CD, Wei GX. Tea as a functional food for oral health. Nutrition18(5), 443–444 (2002).
   PubMed Web of Science ®Google Scholar
• Cabrera C, Artacho R, Gimenez R. Beneficial effects of green tea – a review. J. Am. Coll. Nutr.25(2), 79–99 (2006).
   PubMed Web of Science ®Google Scholar
• Cook RA. Emerging diseases at the interface of people, domestic animals and wildlife. The role of wildlife in our understanding of highly pathogenic avian influenza. Yale J. Biol. Med.78(5), 343–353 (2005).
   PubMedGoogle Scholar
• Fauci AS. Emerging and re-emerging infectious diseases: influenza as a prototype of the host–pathogen balancing act. Cell124(4), 665–670 (2006).
   PubMed Web of Science ®Google Scholar
• Akova M. Emerging problem pathogens: a review of resistance patterns over time. Int. J. Infect. Dis.10(Suppl. 2), S3–S8 (2006).
   Web of Science ®Google Scholar
• Brown JE, Khodr H, Hider RC, Rice-Evans CA. Structural dependence of flavonoid interactions with Cu2+ ions: implications for their antioxidant properties. Biochem. J.330(Pt 3), 1173–1178 (1998).
   PubMed Web of Science ®Google Scholar
• Salah N, Miller NJ, Paganga G, Tijburg L, Bolwell GP, Rice-Evans C. Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch. Biochem. Biophys.322(2), 339–346 (1995).
   PubMed Web of Science ®Google Scholar
• Rice-Evans CA, Miller NJ, Bolwell PG, Bramley PM, Pridham JB. The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic. Res.22(4), 375–383 (1995).
   PubMed Web of Science ®Google Scholar
• Lambert JD, Yang CS. Mechanisms of cancer prevention by tea constituents. J. Nutr.133(10), S3262–S3267 (2003).
   PubMed Web of Science ®Google Scholar
• Cooper R, Morre DJ, Morre DM. Medicinal benefits of green tea: part II. Review of anticancer properties. J. Altern. Complement. Med.11(4), 639–652 (2005).
   PubMed Web of Science ®Google Scholar
• Gensler HL, Timmermann BN, Valcic S et al. Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green tea. Nutr. Cancer26(3), 325–335 (1996).
   PubMed Web of Science ®Google Scholar
• Katiyar SK, Afaq F, Perez A, Mukhtar H. Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis22(2), 287–294 (2001).
   PubMed Web of Science ®Google Scholar
• Mimoto J, Kiura K, Matsuo K et al. (-)-epigallocatechin gallate can prevent cisplatin-induced lung tumorigenesis in A/J mice. Carcinogenesis21(5), 915–919 (2000).
   PubMed Web of Science ®Google Scholar
• Yamane T, Takahashi T, Kuwata K et al. Inhibition of N-methyl-N´-nitro-N-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach. Cancer Res.55(10), 2081–2084 (1995).
   PubMed Web of Science ®Google Scholar
• Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol.42, 25–54 (2002).
   PubMed Web of Science ®Google Scholar
• Wu LY, Juan CC, Hwang LS, Hsu YP, Ho PH, Ho LT. Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Eur. J. Nutr.43(2), 116–124 (2004).
   PubMed Web of Science ®Google Scholar
• Unno K, Takabayashi F, Kishido T, Oku N. Suppressive effect of green tea catechins on morphologic and functional regression of the brain in aged mice with accelerated senescence (SAMP10). Exp. Gerontol.39(7), 1027–1034 (2004).
   PubMed Web of Science ®Google Scholar
• Tian WX, Li LC, Wu XD, Chen CC. Weight reduction by Chinese medicinal herbs may be related to inhibition of fatty acid synthase. Life Sci.74(19), 2389–2399 (2004).
   PubMed Web of Science ®Google Scholar
• Mandel S, Youdim MB. Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic. Biol. Med.37(3), 304–317 (2004).
   PubMed Web of Science ®Google Scholar
• Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet1(8390), 1311–1315 (1984).
   PubMed Web of Science ®Google Scholar
• Uemura N, Okamoto S, Yamamoto S et al.Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med.345(11), 784–789 (2001).
   PubMed Web of Science ®Google Scholar
• Parente F, Cucino C, Bianchi Porro G. Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts. Dig. Liver Dis.35(8), 523–528 (2003).
   PubMedGoogle Scholar
• Wang WH, Wong BC, Mukhopadhyay AK et al. High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong. Aliment. Pharmacol. Ther.14(7), 901–910 (2000).
   PubMed Web of Science ®Google Scholar
• Yee YK, Koo MW. Anti-Helicobacter pylori activity of Chinese tea: in vitro study. Aliment. Pharmacol. Ther.14(5), 635–638 (2000).
   PubMed Web of Science ®Google Scholar
• Mabe K, Yamada M, Oguni I, Takahashi T. In vitro and in vivo activities of tea catechins against Helicobacter pylori.Antimicrob. Agents Chemother.43(7), 1788–1791 (1999).
   PubMed Web of Science ®Google Scholar
• Yanagawa Y, Yamamoto Y, Hara Y, Shimamura T. A combination effect of epigallocatechin gallate, a major compound of green tea catechins, with antibiotics on Helicobacter pylori growth in vitro.Curr. Microbiol.47(3), 244–249 (2003).
   PubMed Web of Science ®Google Scholar
• Matsubara S, Shibata H, Ishikawa F et al. Suppression of Helicobacter pylori-induced gastritis by green tea extract in Mongolian gerbils. Biochem. Biophys. Res. Commun.310(3), 715–719 (2003).
   PubMed Web of Science ®Google Scholar
• Lee KM, Yeo M, Choue JS et al. Protective mechanism of epigallocatechin-3-gallate against Helicobacter pylori-induced gastric epithelial cytotoxicity via the blockage of TLR-4 signaling. Helicobacter9(6), 632–642 (2004).
   PubMed Web of Science ®Google Scholar
• Klugman KP, Koornhof HJ. Worldwide increase in pneumococcal antibiotic resistance. Lancet2(8660), 444 (1989).
   PubMed Web of Science ®Google Scholar
• Update: Staphylococcus aureus with reduced susceptibility to vancomycin – United States, 1997. Morb. Mortal. Wkly Rep.46(35), 813–815 (1997).
   PubMedGoogle Scholar
• Hu ZQ, Zhao WH, Asano N, Yoda Y, Hara Y, Shimamura T. Epigallocatechin gallate synergistically enhances the activity of carbapenems against methicillin-resistant Staphylococcus aureus.Antimicrob. Agents Chemother.46(2), 558–560 (2002).
   PubMed Web of Science ®Google Scholar
• Hu ZQ, Zhao WH, Hara Y, Shimamura T. Epigallocatechin gallate synergy with ampicillin/sulbactam against 28 clinical isolates of methicillin-resistant Staphylococcus aureus.J. Antimicrob. Chemother.48(3), 361–364 (2001).
   PubMed Web of Science ®Google Scholar
• Zhao WH, Hu ZQ, Okubo S, Hara Y, Shimamura T. Mechanism of synergy between epigallocatechin gallate and β-lactams against methicillin-resistant Staphylococcus aureus.Antimicrob. Agents Chemother.45(6), 1737–1742 (2001).
   PubMed Web of Science ®Google Scholar
• Yoda Y, Hu ZQ, Zhao WH, Shimamura T. Different susceptibilities of Staphylococcus and Gram-negative rods to epigallocatechin gallate. J. Infect. Chemother.10(1), 55–58 (2004).
   PubMedGoogle Scholar
• Stapleton PD, Shah S, Anderson JC, Hara Y, Hamilton-Miller JM, Taylor PW. Modulation of β-lactam resistance in Staphylococcus aureus by catechins and gallates. Int. J. Antimicrob. Agents23(5), 462–467 (2004).
   PubMed Web of Science ®Google Scholar
• Stapleton PD, Shah S, Hamilton-Miller JM et al. Anti-Staphylococcus aureus activity and oxacillin resistance modulating capacity of 3-O-acyl-catechins. Int. J. Antimicrob. Agents24(4), 374–380 (2004).
   PubMed Web of Science ®Google Scholar
• Stapleton PD, Shah S, Hara Y, Taylor PW. Potentiation of catechin gallate-mediated sensitization of Staphylococcus aureus to oxacillin by nongalloylated catechins. Antimicrob. Agents Chemother.50(2), 752–755 (2006).
   PubMed Web of Science ®Google Scholar
• Sudano Roccaro A, Blanco AR, Giuliano F, Rusciano D, Enea V. Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells. Antimicrob. Agents Chemother.48(6), 1968–1973 (2004).
   PubMed Web of Science ®Google Scholar
• Gibbons S, Moser E, Kaatz GW. Catechin gallates inhibit multidrug resistance (MDR) in Staphylococcus aureus.Planta Med.70(12), 1240–1242 (2004).
   PubMed Web of Science ®Google Scholar
• Stapleton PD, Gettert J, Taylor PW. Epicatechin gallate, a component of green tea, reduces halotolerance in Staphylococcus aureus.Int. J. Food Microbiol.111(3), 276–279 (2006).
   PubMed Web of Science ®Google Scholar
• Sasaki H, Matsumoto M, Tanaka T et al. Antibacterial activity of polyphenol components in oolong tea extract against Streptococcus mutans.Caries Res.38(1), 2–8 (2004).
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Minami T, Sasaki H, Sobue S, Hamada S, Ooshima T. Inhibitory effects of oolong tea extract on caries-inducing properties of mutans streptococci. Caries Res.33(6), 441–445 (1999).
   PubMed Web of Science ®Google Scholar
• Hirasawa M, Takada K, Otake S. Inhibition of acid production in dental plaque bacteria by green tea catechins. Caries Res.40(3), 265–270 (2006).
   PubMed Web of Science ®Google Scholar
• Pieters J. Entry and survival of pathogenic mycobacteria in bacrophages. Microbes Infect.3(3), 249–255 (2001).
   PubMed Web of Science ®Google Scholar
• Anand PK, Kaul D, Sharma M. Green tea polyphenol inhibits Mycobacterium tuberculosis survival within human macrophages. Int. J. Biochem. Cell Biol.38(4), 600–609 (2006).
   PubMed Web of Science ®Google Scholar
• Friedman M, Henika PR, Levin CE, Mandrell RE, Kozukue N. Antimicrobial activities of tea catechins and theaflavins and tea extracts against Bacillus cereus.J. Food Prot.69(2), 354–361 (2006).
   PubMed Web of Science ®Google Scholar
• Kutikov A, Guzzo TJ, Malkowicz SB. Clinical approach to the prostate: an update. Radiol. Clin. North Am.44(5), 649–663 (2006).
   PubMed Web of Science ®Google Scholar
• Waqenlehner FM, Naber KG. Current challenges in the treatment of complicated urinary tract infections and prostatitis. Clin. Microbiol. Infect.12(3) 67–80 (2006).
   PubMed Web of Science ®Google Scholar
• Lee YS, Han CH, Kang SH et al. Synergistic effect between catechin and ciprofloxacin on chronic bacterial prostatitis rat model. Int. J. Urol.12(4), 383–389 (2005).
   PubMed Web of Science ®Google Scholar
• Isogai E, Isogai H, Hirose K, Hayashi S, Oguma K. In vivo synergy between green tea extract and levofloxacin against enterohemorrhagic Escherichia coli O157 infection. Curr. Microbiol.42(4), 248–251 (2001).
   PubMed Web of Science ®Google Scholar
• Isogai E, Isogai H, Takeshi K, Nishikawa T. Protective effect of Japanese green tea extract on gnotobiotic mice infected with an Escherichia coli O157:H7 strain. Microbiol. Immunol.42(2), 125–128 (1998).
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Matsunaga K, Friedman H. Protective effects of green tea catechins on alveolar macrophages against bacterial infections. Biofactors21(1–4), 119–121 (2004).
   PubMed Web of Science ®Google Scholar
• Park BJ, Park JC, Taguchi H, Fukushima K, Hyon SH, Takatori K. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts. Biochem. Biophys. Res. Commun.347(2), 401–405 (2006).
   PubMed Web of Science ®Google Scholar
• Hirasawa M, Takada K. Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans.J. Antimicrob. Chemother.53(2), 225–229 (2004).
   PubMed Web of Science ®Google Scholar
• Yamazaki T, Kishimoto T, Shiga S et al. Biosynthesized tea polyphenols inactivate Chlamydia trachomatisin vitro.Antimicrob. Agents Chemother.49(6), 2501–2503 (2005).
   PubMed Web of Science ®Google Scholar
• Kajiya K, Hojo H, Suzuki M, Nanjo F, Kumazawa S, Nakayama T. Relationship between antibacterial activity of (+)-catechin derivatives and their interaction with a model membrane. J. Agric. Food Chem.52(6), 1514–1519 (2004).
   PubMed Web of Science ®Google Scholar
• Taguri T, Tanaka T, Kouno I. Antimicrobial activity of 10 different plant polyphenols against bacteria causing food-borne disease. Biol. Pharm. Bull.27(12), 1965–1969 (2004).
   PubMed Web of Science ®Google Scholar
• Park KD, Park YS, Cho SJ et al. Antimicrobial activity of 3-O-acyl-(-)-epicatechin and 3-O-acyl-(+)-catechin derivatives. Planta Med.70(3), 272–276 (2004).
   PubMed Web of Science ®Google Scholar
• Kim YJ, Uyama H, Kobayashi S. Inhibition effects of (+)-catechin-aldehyde polycondensates on proteinases causing proteolytic degradation of extracellular matrix. Biochem. Biophys. Res. Commun.320(1), 256–261 (2004).
   PubMed Web of Science ®Google Scholar
• Nance CL, Shearer WT. Is green tea good for HIV-1 infection? J. Allergy Clin. Immunol.112(5), 851–853 (2003).
   PubMed Web of Science ®Google Scholar
• Williamson MP, McCormick TG, Nance CL, Shearer WT. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: potential for HIV-1 therapy. J. Allergy Clin. Immunol.118(6), 1369–1374 (2006).
   PubMed Web of Science ®Google Scholar
• Nakane H, Ono K. Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases. Biochemistry29(11), 2841–2845 (1990).
   PubMed Web of Science ®Google Scholar
• Fassina G, Buffa A, Benelli R, Varnier OE, Noonan DM, Albini A. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. AIDS16(6), 939–941 (2002).
   PubMed Web of Science ®Google Scholar
• Liu S, Lu H, Zhao Q et al. Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41. Biochim. Biophys. Acta1723(1–3), 270–281 (2005).
   PubMed Web of Science ®Google Scholar
• Nakayama M, Suzuki K, Toda M, Okubo S, Hara Y, Shimamura T. Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral Res.21(4), 289–299 (1993).
   PubMed Web of Science ®Google Scholar
• Song JM, Lee KH, Seong BL. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res.68(2), 66–74 (2005).
   PubMed Web of Science ®Google Scholar
• Imanishi N, Tuji Y, Katada Y et al. Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells. Microbiol. Immunol.. 46(7), 491–494 (2002).
   PubMed Web of Science ®Google Scholar
• Carr CM, Kim PS. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell73(4), 823–832 (1993).
   PubMed Web of Science ®Google Scholar
• Palamara AT, Nencioni L, Aquilano K et al. Inhibition of influenza A virus replication by resveratrol. J. Infect. Dis.191(10), 1719–1729 (2005).
   PubMed Web of Science ®Google Scholar
• Chang LK, Wei TT, Chiu YF et al. Inhibition of Epstein–Barr virus lytic cycle by (-)-epigallocatechin gallate. Biochem. Biophys. Res. Commun.301(4), 1062–1068 (2003).
   PubMed Web of Science ®Google Scholar
• Yan Z, Yong-Guang T, Fei-Jun L, Fa-Qing T, Min T, Ya C. Interference effect of epigallocatechin-3-gallate on targets of nuclear factor κB signal transduction pathways activated by EB virus encoded latent membrane protein 1. Int. J. Biochem. Cell Biol.36(8), 1473–1481 (2004).
   PubMed Web of Science ®Google Scholar
• Uesato S, Taniuchi K, Kumagai A et al. Inhibitory effects of 3-O-acyl-(+)-catechins on Epstein–Barr virus activation. Chem. Pharm. Bull. (Tokyo)51(12), 1448–1450 (2003).
   PubMed Web of Science ®Google Scholar
• Savi LA, Barardi CR, Simoes CM. Evaluation of antiherpetic activity and genotoxic effects of tea catechin derivatives. J. Agric. Food Chem.54(7), 2552–2557 (2006).
   PubMed Web of Science ®Google Scholar
• Lyu SY, Rhim JY, Park WB. Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro.Arch. Pharm. Res.28(11), 1293–1301 (2005).
   PubMed Web of Science ®Google Scholar
• Sonoda J, Koriyama C, Yamamoto S et al. HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking. Cancer Sci.95(7), 596–601 (2004).
   PubMed Web of Science ®Google Scholar
• Weber JM, Ruzindana-Umunyana A, Imbeault L, Sircar S. Inhibition of adenovirus infection and adenain by green tea catechins. Antiviral Res.58(2), 167–173 (2003).
   PubMed Web of Science ®Google Scholar
• Clark KJ, Grant PG, Sarr AB et al. An in vitro study of theaflavins extracted from black tea to neutralize bovine rotavirus and bovine coronavirus infections. Vet. Microbiol.63(2–4), 147–157 (1998).
   PubMed Web of Science ®Google Scholar
• Mukoyama A, Ushijima H, Nishimura S et al. Inhibition of rotavirus and enterovirus infections by tea extracts. Jpn J. Med. Sci. Biol.44(4), 181–186 (1991).
   PubMedGoogle Scholar
• Yokoyama M, Noguchi M, Nakao Y, Pater A, Iwasaka T. The tea polyphenol, (-)-epigallocatechin gallate effects on growth, apoptosis, and telomerase activity in cervical cell lines. Gynecol. Oncol.92(1), 197–204 (2004).
   PubMed Web of Science ®Google Scholar
• Ahn W, Yoo J, Huh S et al. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur. J. Cancer Prev.12(5), 383–390 (2003).
   PubMed Web of Science ®Google Scholar
• Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev. Med.21(3), 334–350 (1992).
   PubMed Web of Science ®Google Scholar
• Guan Y, Poon LL, Cheung CY et al. H5N1 influenza: a protean pandemic threat. Proc. Natl Acad. Sci. USA101(21), 8156–8161 (2004).
   PubMed Web of Science ®Google Scholar